COMPREHENSIVE CODE LIST ASSOCIATED WITH CDC-DEFINED HIGH-RISK UNDERLYING MEDICAL CONDITIONS LEADING TO POTENTIAL PROGRESSION TO SEVERE COVID-19 OUTCOMES

被引：0
|
作者：
Scott, A. [1 ]
Draica, F. [1 ]
Atkinson, J. [2 ]
Chambers, R. [3 ]
Reimbaeva, M. [4 ]
Stanford, R. [5 ]
Edgecomb, A. [5 ]
Manuel, F. [5 ]
机构：
[1] Pfizer Inc, New York, NY USA
[2] Pfizer LTD, Tadworth, England
[3] Pfizer Inc, Collegeville, PA USA
[4] Pfizer Inc, Groton, CT 06340 USA
[5] AESARA Inc, Chapel Hill, NC USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD70
引用
收藏
页码：S373 / S374
页数：2
相关论文
共 16 条
  • [1] Underlying medical conditions associated with severe COVID-19
    Mellis, Craig
    [J]. JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2021, 57 (10) : 1722 - 1723
  • [2] Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children
    Kompaniyets, Lyudmyla
    Agathis, Nickolas T.
    Nelson, Jennifer M.
    Preston, Leigh Ellyn
    Ko, Jean Y.
    Belay, Brook
    Pennington, Audrey F.
    Danielson, Melissa L.
    DeSisto, Carla L.
    Chevinsky, Jennifer R.
    Schieber, Lyna Z.
    Yusuf, Hussain
    Baggs, James
    Mac Kenzie, William R.
    Wong, Karen K.
    Boehmer, Tegan K.
    Gundlapalli, Adi V.
    Goodman, Alyson B.
    [J]. JAMA NETWORK OPEN, 2021, 4 (06) : E2111182
  • [3] Fruits and Vegetables in the Management of Underlying Conditions for COVID-19 High-Risk Groups
    Moreb, Nora A.
    Albandary, Ahmed
    Jaiswal, Swarna
    Jaiswal, Amit K.
    [J]. FOODS, 2021, 10 (02)
  • [4] Is Plasma Therapy useful in High-Risk Patients with severe COVID-19 Progression?
    Lichert, Frank
    [J]. TRANSFUSIONSMEDIZIN, 2023, 13 (02) : 72 - 73
  • [5] Effectiveness of Regdanvimab Treatment in High-Risk COVID-19 Patients to Prevent Progression to Severe Disease
    Lee, Ji Yeon
    Lee, Jee Young
    Ko, Jae-Hoon
    Hyun, Miri
    Kim, Hyun Ah
    Cho, Seongcheol
    Lee, Yong Dae
    Song, Junghoon
    Shin, Seunghwan
    Peck, Kyong Ran
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [6] Prevalence of Underlying Medical Conditions Associated With Severe COVID-19 Illness in Adult Cancer Survivors in the United States
    Jiang, Changchuan
    Yabroff, K. Robin
    Deng, Lei
    Perimbeti, Stuthi
    Han, Xuesong
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (01) : 156 - 159
  • [7] Balancing the Effects of COVID-19 Against Potential Progression and Mortality in High-risk Prostate Cancer
    Moschovas, Marcio Covas
    Sighinolfi, Maria Chiara
    Rocco, Bernardo
    Bhat, Seetharam
    Onol, Fikret
    Rogers, Travis
    Patel, Vipul
    [J]. EUROPEAN UROLOGY, 2020, 78 (01) : E14 - E15
  • [8] Impact of COVID-19 on the associated complications of high-risk conditions in a statewide pediatric emergency network
    Mangus, Courtney W.
    Parker, Sarah J.
    DeLaroche, Amy M.
    Zhang, Xingyu
    Gunnink, Stephen
    Hayes, Julia
    Heath, Gerard
    Michiels, Erica
    Mahajan, Prashant
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN, 2022, 3 (06)
  • [9] Estimated County-Level Prevalence of Selected Underlying Medical Conditions Associated with Increased Risk for Severe COVID-19 Illness United States, 2018
    Razzaghi, Hilda
    Wang, Yan
    Lu, Hua
    Marshall, Katherine E.
    Dowling, Nicole F.
    Paz-Bailey, Gabriela
    Twentyman, Evelyn R.
    Peacock, Georgina
    Greenlund, Kurt J.
    [J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (29):
  • [10] Population-based Estimates or High Risk of Severe COVID-19 Disease due to Age and Underlying Health Conditions
    Laires, Pedro A.
    Nunes, Carla
    [J]. ACTA MEDICA PORTUGUESA, 2020, 33 (11) : 720 - 725
12